SMH
ORTX

Sanders Morris Harris’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Sanders Morris Harris’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,250
Closed -$55K – 263
2023
Q1 		$55K Buy
+10,250
New +$55.7K 0.02% 134

Other funds holding ORTX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Sanders Morris Harris's ORTX Position: Q2 2023 in Review

Sanders Morris Harris sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2023, closing a stake of 10,250 shares — an estimated $55K sold.

Sanders Morris Harris first reported a position in ORTX in Q1 2023 and held it in 1 quarter. The position peaked at $55K in Q1 2023. 33 funds tracked by Wall St. Rank hold ORTX as of Q2 2023.

  • Sanders Morris Harris reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Sanders Morris Harris sold 10,250 Orchard Therapeutics plc American Depositary Shares shares in Q2 2023, an estimated $55K.
  • Sanders Morris Harris first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2023 and held it in 1 quarter.
  • Sanders Morris Harris's Orchard Therapeutics plc American Depositary Shares position peaked at $55K in Q1 2023.
  • 33 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2023.

Based on Sanders Morris Harris's 13F filing for Q2 2023, filed 11 Jul 2023.